Trial NCT03827044

View at ClinicalTrials.gov 
Org. Study IDs: CCR 4673 POLEM

Last trial update was posted on 2022-10-07

MeSH Interventions

Avelumab

MeSH Conditions

Colonic Neoplasms Microsatellite Instability

Other Conditions

POLE Exonuclease Mutant Colon Cancer Stage III Colon Cancer

Stopping Reasons

POLEM encountered significant recruitment challenges. With little prospect of recruiting to target the decision to close was made.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID